The PennZone

  • Home
  • Non-profit
  • Education
  • Technology
  • Business
  • Construction
  • Entertainment
  • Event
  • Sports

Carisma Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference
The PennZone/10289107

Trending...
  • Pittsburgh-Area Author Erica L. Day Releases HER, a Christian Second-Chance Romance and Its Own Comp
  • MoMojo Records announces new album from Mitch Woods
  • Boston Industrial Solutions Launches Natron® 348 UV Inkjet Ink for Epson S3200 Print Heads
PHILADELPHIA, Nov. 27, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: https://www.prnewswire.com/news-releases/#finan..." rel="nofollow">CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference on Thursday, December 5th at 9:35 am ET.

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

More on The PennZone
  • Golden Visa Countries Outpace Eurozone Growth Over Eight Years, New La Vida Analysis Finds
  • Allstream Energy Partners Announced as Official Media Partner for the 2nd Annual Permian Power Conference
  • Wine School of Philadelphia Celebrates 25 Years With Intensive Summer Program
  • Greensburg Pennsylvania Martial Arts School Racks Up BJJ Wins
  • Dave's Auto Services Sponsors Night of Racing at Action Track USA in Kutztown PA

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
[email protected]

Media Contact:
Julia Stern
(763) 350-5223
[email protected]

SOURCE Carisma Therapeutics Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED
Filed Under: Business

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • A Foundational Claim in Human Secrecy Goes Public
  • Agape Leadership Academy Opens Nationwide Enrollment — State ESA Scholarships Cover Full Tuition for Families in 7 States
  • Fourth Annual Free Training Day Mid-Atlantic Returns Sept. 19, 2026
  • Las Vegas Headliner Don Barnhart Brings National Touring Comedy Show to Comedy Cabana
  • Nevada Boxing Hall of Fame Announces 14th Annual Induction Gala Weekend Honoring Classes of 2025 and 2026
  • Brosix Celebrates 20 Years of Private Team Messaging for Small and Mid-Sized Businesses
  • Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
  • Colonial Nissan Enhances Ownership Experience with Hall of Fame Package
  • From Broken to Soaring Week 40
  • Costa Oil Takes the Spotlight as Primary Sponsor at Pocono, Celebrates Team with Employee Appreciation Day Costa Oil to back the
  • MoMojo Records announces new album from Mitch Woods
  • Finnish Political Satire Film Generates 10,000+ Cross-Platform Interactions Following Gandalf Parody Video Across TikTok, YouTube and Telegram
  • Baikal Engineers Published in ASHRAE Journal on Site-Assembled Custom AHUs
  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
  • Eichelberger Performing Arts Center Announces Fall 2026 Performance Lineup
  • netElastic Powers LigaT's High-Performance Broadband Expansion and IPv6 Modernization in Portugal
  • IWS Press Expands Best-Selling Classic Wealth Library with Seventh Book
  • Raiku launches rkuSOL with Sanctum, Kamino, Loopscale and Exponent
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates

Popular on PennZone

  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan - 121
  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach - 103
  • All About Technology Celebrates 25 Years of Bridging Detroit's Digital Divide
  • Edwards & Virginia Business Systems Announces Leadership Appointments
  • T. Jones Group Named Finalist Across Multiple Categories at the 2026 Georgie Awards
  • Calvetta Phair, CEO America's Workforce Solution, LLC Assessed "Awardable" for Department of War work in the CDAO's Tradewinds Solutions Marketplace
  • SRK Collective Media Group Launches with a Modern Approach to Media, Authority Building, and Cultural Visibility
  • Ed, Edd n Eddy, Resident Evil, Anime Voice Actors Augment FAN EXPO Philadelphia Lineup
  • The Simplest Small Business You're Probably Not Thinking About
  • Love Must Be the Guide: Live Good Shares a Message of Humanity, Compassion and Hope

Similar on PennZone

  • PropAccount.com Launches PropGenie, the First Branding Studio Built for Prop Firm Operators
  • Rushing Headlong: Health IT's Legacy and the Road to Responsible AI is named 2025 Foreword INDIES Book of the Year Awards Winner
  • The Problem With AI Isn't Compute. It's Memory
  • Golden Visa Countries Outpace Eurozone Growth Over Eight Years, New La Vida Analysis Finds
  • Top 15 Mosquito-Infested Cities in Louisiana and East Texas Ranked for 2026 Mosquito Season
  • AI Is Making It Easier for API-First Platforms to Connect, Partner, Reach Customers, and Grow Revenue Faster
  • 2026 Editorial Freelancers Association Conference Focuses on Building Sustainable Careers
  • Greenland Mines Ltd (N A S D A Q: GRML) Advances Strategic Growth Initiatives as Critical Minerals Demand Accelerates
  • Entering the $69 Billion Animal Health Market, Delivering Record Growth, AI-Driven Healthcare Innovation, and Targeting $200 Million Revenue by 2029
  • $97.9 Million Q1 Revenue Growth Reinforces Transformation Into a Global AI & Digital Services Powerhouse: IQSTEL, Inc. (N A S D A Q: IQST)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us